HBSP (USA)
-
BeiGene
Shih, Willy; Zhang, JimmyCase HBS-618033-EStrategyBeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeStarting at €8.20
-
BeiGene, PowerPoint Supplement
Shih, Willy; Zhang, JimmyCase HBS-618043-EStrategyPowerPoint slides for case 618033.Starting at €8.20
-
-
Sino-Forest (A) (B) (C), Teaching Note
Hawkins, David F.Teaching Note HBS-112068-EAccounting and ControlTeaching Note for 112004.Starting at €0.00
-
Longtop Financial Technologies (B)
Hawkins, David F.; Lobb, Annelena; Sesia, AldoCase HBS-112037-EAccounting and ControlNo abstract available.Starting at €5.74
-
Longtop Financial Technologies (C)
Hawkins, David F.; Lobb, Annelena; Sesia, AldoCase HBS-112038-EAccounting and ControlChinese government raises barriers to U.S. Public Company Accounting Oversight Board auditing Deloitte's Chinese auditing firms.Starting at €5.74
-
Sino-Forest (B)
Hawkins, David F.Case HBS-112066-EAccounting and ControlExcerpts from a hedge fund's report accusing a Chinese bond company of using fraudulent financial statements.Starting at €5.74
-
BeiGene, Teaching Note
Shih, Willy; Zhang, JimmyTeaching Note HBS-618039-EStrategyTeaching Note for 618033 BeiGene. BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window of opportunity to develop drug candidates toward known targets with known mechanisms of actions that would allow it to become first-in-class in Ch...Starting at €0.00
-
Sino-Forest (A)
Hawkins, David F.; Lane, DavidCase HBS-112004-EAccounting and ControlA Chinese company listed on the Toronto Stock Exchange is accused of fraud by a hedge fund.Starting at €8.20